"(NaturalNews) Patients who take the cholesterol drug torcetrapid, intended to increase levels of HDL ('good') cholesterol and lower LDL ('bad') cholesterol levels, have a 58 percent higher risk of death than similar patients who do not take the drug, according to a study led by researchers at the Heart Research Institute in Sydney and published in the New England Journal of Medicine.
Researchers studied 15,067 participants, all considered to be at high risk of cardiovascular disease. All the patients were treated with the cholesterol-lowering drug atorvastatin, while half were also treated with torcetrapid." click here to read the rest of "Pfizer's Cholesterol Drug Boosts Death Rate by 58 Percent" at naturalnews.com
